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1. Introduction 
Hormones and other polypeptides secreted by cells 
are frequently biosynthesized as larger precursors. 
The necessary enzymic processing of these occurs prior 
to the secretion of hormones but after the secretion 
of blood factors and zymogens. These conversion 
processes are of particular importance in regulatory 
mechanisms [l] such as blood clotting. At present, 
the mechanisms of conversion from precursors to 
hormones are poorly understood in all but a few 
instances. Furthermore, hormones themselves are 
sometimes found as several homologous species, each 
with some activity, but differing in peptide length 
[2,3] . A clearer understanding of the intracellular 
processing events may help to distinguish between 
primary hormonal products and artefacts produced 
by non-specific enzyme attack [4] . 
A general mechanism for the intracellular process- 
ing of propolypeptides has been proposed. In this a 
trypsin-like enzyme cuts precursors specifically at 
adjacent basic ammo acids. The resulting basic COOH- 
terminal residues are then removed by a carboxy- 
peptidase B-like enzyme [5,6] . An example is the 
release of the C-peptide from proinsulin by cleavage 
at the carboxyl ends of -Arg-Arg- and -Lys-Arg- 
sequences. Both trypsin and carboxypeptidase B-like 
activities have been observed during the conversion 
of proparathyrin [ 161. 
It is not known whether these enzymes are the 
same in all cells producing secretory material, or 
whether they are specific to particular polypeptides. 
For example albumin, glucagon and parathyrin all 
retain paired basic amino acid sequences, although 
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their precursors are cleaved at identical or analogous 
residues. The present report indicates that the 
apparently high specificity of conversion may arise 
from readily predictable conformational properties 
of the precursors. The observations support a growing 
view that there are a limited number of converting 
enzymes with a wide cellular distribution. 
2. Structure prediction methods 
Regions of secondary structure were located in 
sequences published [ 191 by using the empirical rules 
in [9] . a-Helix and /3-structure were deduced using 
recent tabulations of structure-formation parameters 
[20]. Beta-turns were located by computation of 
cumulative probabilities for tetrapeptides to form a 
reverse turn [21]. If extended regions of overlapping 
reverse turns were predicted by this method (due to 
a high frequency of serine, glycine and proline 
residues), the tetrapeptide with the highest probability 
of p-turn formation was chosen. Where appropriate, 
information from species variants was used in deciding 
structure. Usually sequence differences were not 
sufficient to alter the predicted secondary structure 
significantly. 
3. Results and discussion 
Ammo acid sequences of precursors which contain 
pairs of basic residues are listed in table 1. An inspection 
of these did not reveal any additional features which 
could account for the restriction of proteolysis to the 
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Table 1 
The sequences at double basic sites in propolypeptides 
Propolypeptide Processing sites Sites not processed 
Proalbumin 
(Human) 
Proparathyrin 
(Bovine) 
Proglucagon 
(Porcine) 
Progastrin 
(Porcine) 
Proinsulin 
(Porcine) 
Lipotropin 
(Porcine) 
5 
v -Gly-V&Phe-ARG-ARG-Asp-Ala-His- -Glu-Ile-Ala-ARG-ARG-His-Pro-Tyr- 
-Glu-Tyr-Ala-ARG-ARG-His-Pro-Asp- 
-Arg-Tyr-Thr-LYS-LYS-Val-Pro-Gln- 
5 
v -Ser-Val-Lys-LYS--ARG-Ala-Val-Ser- -Trp-Leu-ARG-LYS-LYS-Leu-Gln-Asp- 
-Arg-Pro-ARG-LYS-LYS-Glu-Asp-Asn- 
3c 
v -Met-Asn-Thr-LYS--ARG-Asn-Lys-Asn- -Leu-Asp-Ser-ARG-ARG-Ala-Gln-Asp- 
15 
v -Asp-Pro-Ser-LYS-LYS-Gln-Gly-Pro- 
30 
v -Pro-Lys-Ala-ARG-ARG-Glu-Ala-Glu- 
65 
v -Pro-Pro-Gln-LYS-ARG-Gly-Ile-Val- 
40 
v -Ala-Ala-Glu-LYS-LYS-Asp-Glu-Gly- 
60 
v -Pro-Lys-Asp-LYS-ARG-Tyr-Gly-Gly- 
v 90 -Asn-Ala-His-LYS-LYS-Gly-Gln-OH 
indicated sites. The observed selectivity must therefore 
result either from the existence of very specific 
converting enzymes or from the inaccessibility of 
some double basic sequences to these enzymes. This 
latter alternative appears unlikely since lysine and 
arginine invariably appear on the surface of globular 
proteins, particularly in this instance where they 
occur in pairs. A more acceptable explanation would 
be that unprocessed sequences occur in a rigid con- 
formation, such as an a-helix, and are thus poor sub- 
strates for enzymes. This idea is supported by the 
known ability of trypsin in small amounts to release 
active peptides from precursors. It should be noted 
that the pancreatic enzyme has the potential to split 
at any site containing a basic residue, so that the 
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activation sites of precursors must be uniquely sus- 
ceptible to tryptic attack. 
Although small polypeptides do not generally 
possess econdary or tertiary structure in solution, 
their higher molecular weight precursors probably do 
have defined folding. Only proparathyrin, proinsulin 
and proalbumin represent the complete precursor 
structures in table 1, and the latter two are known to 
be structured in dilute solution. In order to examine 
the hypothesis that unprocessed paired basic sequences 
occur in elements of secondary structure, o-helix and 
p-strands were located exactly from known crystal 
structures or to a good approximation by the empirical 
rules in [9] . The results are recorded in fig.1. 
All the known precursor processing sites were 
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Fig. 1. Secondary structure predicted in propolypeptides and hormones containing double basic residue sequences. Filled rectangles 
refer to P-turns, empty rectangles represent a-helix and hatched rectangles represent p-structure. The numbers indicate the 
boundaries of the secondary structural elements. Arrows mark known sites of precursor processing. These have been firmly estab- 
lished in the cases of lipotropin [ 81 and proinsulin [ 71. Circles represent lysine (filled) and arginine (empty). The secondary 
structure shown for the A and B chains of insulin was taken from the published X-ray structure [ 171. Predictions of the proinsulin 
structure are in [ 181. The arrow above the glucagon structure indicates the.extent of a-helix present in the crystal structure of 
glucagon [lo]. The proalbumin NH, region only is shown because of the length of this molecule. 
located in unstructured regions of the polypeptide 
chain or at an a-helix boundary. These sites were 
frequently found to be close to reverse turns in the 
polypeptide chain. On the other hand, paired basic 
sequences not split by processing were invariably 
found in predicted a-helical regions: -Arg-Lys-Lys- 
in proparathyrin, -Lys-Lys- and -Arg-Arg- 
sequences in proalbumin. The unprocessed -Arg-Arg- 
sequence in proglucagon is in the centre of a predicted 
a-helix. The same feature is present at this position 
in the glucagon crystal structure [lo] . Of 9 unpro- 
cessed paired basic amino acid sequences in human 
albumin only 3 occur outside regions of predicted 
secondary structure [ 1 l] . However, these sites 
appear to be inaccessible to both trypsin [ 121 and 
pepsin [13,14]. 
On the basis of this model of precursor processing, 
one might predict that after formation, small hor- 
mones such as glucagon and lipotropin or its fragments 
would be further cleaved by the trypsin-like enzyme. 
These two hormones do not appear to have secondary 
structure in dilute solution. It is, however, a common 
feature of small polypeptide hormones that they 
become highly associated even at moderate concentra- 
tions. This association process is known to induce 
secondary structure in glucagon [ 1.51. The rate of 
proteolysis of glucagon by trypsin was found to be 
markedly slowed as the concentration of the hormone 
was increased [22] . At the concentrations which 
occur in mature storage granules, insulin and glucagon 
actually crystallize [lo] . Under such conditions it is 
evident that no further proteolysis can occur until 
the secretory event itself. 
It is proposed that precursor processing is restricted 
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to relatively flexible regions of the folded molecules 
at double basic recognition sites. The polar nature of 
basic residues as well as the proximity of processing 
sites to reverse turns indicates that these sites have a 
superficial location, where they are accessible to 
enzymes. On the other hand, it is predicted that 
double basic sequences essential to the structure and 
function of the products of processing are restricted 
to regions of secondary structure. Although these 
potential sites may also be accessible to enzymes 
they are maintained in a rigid conformation by 
hydrogen bonding and thus represent a poor substrate 
for proteolytic enzymes. 
The consistency of the above observations, as 
applied to the known precursors, demonstrates that 
empirical structural rules may be used to locate poten- 
tial processing sites. This model of propolypeptide 
processing represents a considerable economy, since 
the specificity of conversion is achieved by precursor 
conformation and not by the elaboration of many 
individual converting enzymes. It will be interesting 
to see how this model can be applied as the sequences 
of more precursors become known. 
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